Role of N-linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor

被引:40
|
作者
Chen, Quan [1 ]
Miller, Laurence J. [1 ]
Dong, Maoqing [1 ]
机构
[1] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2010年 / 299卷 / 01期
关键词
G protein-coupled receptor; ligand binding; receptor biological activity; receptor cell surface expression; CELL-SURFACE EXPRESSION; PROTEIN-COUPLED RECEPTORS; SECRETIN RECEPTOR; LIGAND-BINDING; AT(1) RECEPTOR; OLIGOSACCHARIDES; ACTIVATION; DOMAIN; SITES;
D O I
10.1152/ajpendo.00067.2010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chen Q, Miller LJ, Dong M. Role of N-linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor. Am J Physiol Endocrinol Metab 299: E62-E68, 2010. First published April 20, 2010; doi:10.1152/ajpendo.00067.2010.-The family B G protein-coupled glucagon-like peptide 1 (GLP-1) receptor is an important drug target for treatment of type 2 diabetes. Like other family members, the GLP-1 receptor is a glycosylated membrane protein that contains three potential sites for N-linked glycosylation within the functionally important extracellular amino-terminal domain. However, the roles for each potential site of glycosylation in receptor biosynthesis, trafficking, and function are not known. In this work, we demonstrated that tunicamycin inhibition of glycosylation of the GLP-1 receptor expressed in CHO cells interfered with biosynthesis and intracellular trafficking, thereby eliminating natural ligand binding. To further investigate the roles of each of the glycosylation sites, site-directed mutagenesis was performed to eliminate these sites individually and in aggregate. Our results showed that mutation of each of the glycosylation sites individually did not interfere with receptor expression on the cell surface, ligand binding, and biological activity. However, simultaneous mutation of two or three glycosylation sites resulted in almost complete loss of GLP-1 binding and severely impaired biological activity. Immunostaining studies demonstrated receptor biosynthesis but aberrant trafficking, with most of the receptor trapped in the endoplasmic reticulum and golgi compartments and little of the receptor expressed on the cell surface. Interestingly, surface expression, ligand binding, and biological activity of these mutants improved significantly when biosynthesis was slowed using low temperature (30 degrees C). These data suggest that N-linked glycosylation of the GLP-1 receptor is important for its normal folding and trafficking to the cell surface.
引用
收藏
页码:E62 / E68
页数:7
相关论文
共 50 条
  • [41] Small Molecule Drug Discovery at the Glucagon-Like Peptide-1 Receptor
    Willard, Francis S.
    Bueno, Ana B.
    Sloop, Kyle W.
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [42] N-linked glycosylation plays a crucial role in the secretion of HMGB1
    Kim, Young Hun
    Kwak, Man Sup
    Park, Jun Bae
    Lee, Shin-Ae
    Choi, Ji Eun
    Cho, Hyun-Soo
    Shin, Jeon-Soo
    JOURNAL OF CELL SCIENCE, 2016, 129 (01) : 29 - 38
  • [43] Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor
    Kirkpatrick, Andrea
    Heo, Jiyoung
    Abrol, Ravinder
    Goddard, William A., III
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (49) : 19988 - 19993
  • [44] Attenuated diuresis and natriuresis in response to glucagon-like peptide-1 in hypertensive rats are associated with lower expression of the glucagon-like peptide-1 receptor in the renal vasculature
    Savignano, Fernanda A.
    Crajoinas, Renato O.
    Pacheco, Bruna P. M.
    Campos, Luciene C. G.
    Shimizu, Maria Heloisa M.
    Seguro, Antonio Carlos
    Girardi, Adriana C. C.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 811 : 38 - 47
  • [45] Paraventricular Thalamic Control of Food Intake and Reward: Role of Glucagon-Like Peptide-1 Receptor Signaling
    Ong, Zhi Yi
    Liu, Jing-Jing
    Pang, Zhiping P.
    Grill, Harvey J.
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 (12) : 2387 - 2397
  • [46] Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R)
    Yang, Dehua
    de Graaf, Chris
    Yang, Linlin
    Song, Gaojie
    Dai, Antao
    Cai, Xiaoqing
    Feng, Yang
    Reedtz-Runge, Steffen
    Hanson, Michael A.
    Yang, Huaiyu
    Jiang, Hualiang
    Stevens, Raymond C.
    Wang, Ming-Wei
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (25) : 12991 - 13004
  • [47] A Novel Interacting Protein SERP1 Regulates the N-Linked Glycosylation and Function of GLP-1 Receptor in the Liver
    Xiao, Yuanyuan
    Han, Junfeng
    Wang, Qianqian
    Mao, Yueqin
    Wei, Meilin
    Jia, Weiping
    Wei, Li
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (11) : 3616 - 3626
  • [48] Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis
    Sawada, Noritaka
    Adachi, Kei
    Nakamura, Nobuhisa
    Miyabe, Megumi
    Ito, Mizuho
    Kobayashi, Shuichiro
    Miyajima, Shin-ichi
    Suzuki, Yuki
    Kikuchi, Takeshi
    Mizutani, Makoto
    Toriumi, Taku
    Honda, Masaki
    Mitani, Akio
    Matsubara, Tatsuaki
    Naruse, Keiko
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [49] The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury
    Hrkac, Anja Harej
    Pilipovic, Kristina
    Belancic, Andrej
    Juretic, Lea
    Vitezic, Dinko
    Mrsic-Pelcic, Jasenka
    PHARMACEUTICALS, 2024, 17 (10)
  • [50] Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2
    Rowland, Raymond
    Brandariz-Nunez, Alberto
    MICROBIOLOGY SPECTRUM, 2021, 9 (02):